Dr. Jeremy Y. Chuang, MD

Dr. Chuang practices at PIH Health Whittier Hospital in Whittier, California, part of PIH Health.

Dr. Chuang's NPI, 1902269541, was assigned on March 31, 2016. Dr. Chuang graduated from Zucker School of Medicine in 2016. Dr. Chuang holds California license A151308.

Dr. Chuang's primary practice is PIH Health Whittier Hospital, at 12401 Washington Blvd, Whittier, CA 90602 in Los Angeles County. The practice phone is (562) 698-0811.

Dr. Chuang's primary practice is PIH Health Whittier Hospital in Whittier, California, part of PIH Health. Dr. Chuang is also affiliated with PIH Health Downey Hospital. The medical group on file is PIH Health Physicians. Dmand AI also links Dr. Chuang to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chuang practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Chuang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Chuang is board certified in hematology by the American Board of Internal Medicine. Dr. Chuang is licensed in California.

Dmand AI lists atrial fibrillation and flutter, chronic anemia, chronic embolism thrombosis, chronic kidney disease, cirrhosis of the liver, deep vein thrombosis (DVT), gastroenteritis and osteoporosis among the conditions Dr. Chuang treats.

CMS data shows 803 Medicare services from Dr. Chuang across 11 procedure codes in 2024, for 137 Medicare patients. Medicare paid $58,438 for them.

CMS counts 137 Medicare patients who saw Dr. Chuang in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chuang's median patient age at 71, with 62% women.

In 2024, Dr. Chuang wrote 636 Medicare Part D claims for 168 patients. 79% of them were for generic drugs. CMS names the drug for 488 of them, across 16 drugs with 11 or more claims each, at $160,875 in total drug cost. In 2023, CMS named 459 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Chuang for performance year 2024, reported as part of a group. Dr. Chuang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chuang as offering telehealth.

Dmand AI links 11 papers to Dr. Chuang, published from 2017 to 2022. 2019 was the busiest year, with 2. The most frequent topics are Colorectal Neoplasms and Antineoplastic Combined Chemotherapy Protocols. Dr. Chuang has published most often in Clin Colorectal Cancer. Dr. Chuang's most frequent co-authors are Jun Gong, Andrew Eugene Hendifar, MD, MPH and Joseph Chao, MD.

CMS Open Payments shows 269 general payments to Dr. Chuang from 51 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 92% of the total. Pfizer Inc. paid the most, $612.

Dr. Chuang graduated from Zucker School of Medicine in 2016.

Dr. Chuang is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.